791 Effectiveness and safety of lenvatinib and pembrolizumab (LenPem) therapy for endometrial cancer (EC): Results from a Russian multicenter database

A Tyulyandina; A Kedrova; N Graft; M Ibragimova; T Krashikhina; T Zhelezkova; J Vasilieva; K Maistrenko; O Kuchevskaya; E Markizova; I Stradaeva; E Markarova; A Belonogov; T Ibragomov; E Zorina; I Luev; R Zhikhorev; M Popova; L Vlasova; M Volkonsky

doi:10.1136/ijgc-2021-ESGO.197

Article info

Endometrial cancer

791 Effectiveness and safety of lenvatinib and pembrolizumab (LenPem) therapy for endometrial cancer (EC): Results from a Russian multicenter database

Free

Authors

A Tyulyandina NN Blokhin Russian Cancer Research Centre, Moscow, Russian Federation PubMed articles Google scholar articles
A Kedrova Federal scientific clinical center of specialized types of medical care and medical technologies, Moscow, Russian Federation PubMed articles Google scholar articles
N Graft Moscow Clinical Institute Scientific Center named after A. S. Loginov, Moscow, Russian Federation PubMed articles Google scholar articles
M Ibragimova Moscow City Oncology Hospital #1, Moscow, Russian Federation PubMed articles Google scholar articles
T Krashikhina Lyadov Clinic, Moscow, Russian Federation PubMed articles Google scholar articles
T Zhelezkova Moscow City Oncological Hospital #62, Moscow, Russian Federation PubMed articles Google scholar articles
J Vasilieva Moscow City Oncological Hospital #62, Moscow, Russian Federation PubMed articles Google scholar articles
K Maistrenko Moscow City Clinical Hospital #40, Moscow, Russian Federation PubMed articles Google scholar articles
O Kuchevskaya Moscow City Clinical Hospital #40, Moscow, Russian Federation PubMed articles Google scholar articles
E Markizova Moscow City Clinical Hospital #40, Moscow, Russian Federation PubMed articles Google scholar articles
I Stradaeva PET Technology Clinic, Moscow, Russian Federation PubMed articles Google scholar articles
E Markarova Moscow Regional Research and Clinical Institute, Moscow, Russian Federation PubMed articles Google scholar articles
A Belonogov Odintsovo Central Regional Hospital, Moscow, Russian Federation PubMed articles Google scholar articles
T Ibragomov Podolsk oncology dispensary, Moscow, Russian Federation PubMed articles Google scholar articles
E Zorina Podolsk oncology dispensary, Moscow, Russian Federation PubMed articles Google scholar articles
I Luev Moscow City Oncological Hospital #62, Moscow, Russian Federation PubMed articles Google scholar articles
R Zhikhorev Moscow City Oncological Hospital #62, Moscow, Russian Federation PubMed articles Google scholar articles
M Popova Moscow Clinical Institute Scientific Center named after A. S. Loginov, Moscow, Russian Federation PubMed articles Google scholar articles
L Vlasova Moscow City Clinical Hospital #40, Moscow, Russian Federation PubMed articles Google scholar articles
M Volkonsky Moscow City Oncological Hospital #62, Moscow, Russian Federation PubMed articles Google scholar articles

Citation

Tyulyandina A, Kedrova A, Graft N, et al

791 Effectiveness and safety of lenvatinib and pembrolizumab (LenPem) therapy for endometrial cancer (EC): Results from a Russian multicenter database

International Journal of Gynecologic Cancer 2021;31:A123-A124.

Publication history

First published October 12, 2021.

Online issue publication

January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password